For T cell malignancies, the 40 kDa transmembrane glycoprotein CD7 is a particularly interesting target as it is expressed in ∼95% of T-ALL and ∼50% of peripheral T cell lymphomas.1 The gene discussed is CD7; the disease is acute lymphoblastic leukemia.